AmreenMDinaniMD

Gastroenterology • Durham, NC

Hepatology & Liver Transplantation

Associate Professor of Medicine, Duke University

Join to view full profile

Dr. Dinani is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Dinani's full profile

Already have an account?

Office
40 Duke Medicine Circle Clinic 2J
Durham, NC 27710
Phone+1 919-681-3180

Education & Training

New York-Presbyterian/QueensResidency, Internal Medicine, 2006 - 2009
American University of the Caribbean School of MedicineClass of 2005

Certifications & Licensure

NH State Medical License 2013 - Present
NC State Medical License 2022 - 2024
NY State Medical License 2016 - 2023
American Board of Internal Medicine Gastroenterology
American Board of Obesity Medicine Obesity Medicine

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013

Publications & Presentations

PubMed

31 citations
Predictors of Outcome in Ulcerative Colitis.
Matti Waterman, Jo Knight, Amreen Dinani, Wei Xu, Joanne M. Stempak
Inflammatory Bowel Diseases. 2015-09-01
10 citations
Environmental exposures are important risk factors for advanced liver fibrosis in African American adults.
Ning Ma, Rowena Yip, Sara Lewis, Amreen Dinani, Christina Wyatt
JHEP Reports. 2023-04-01
27 citations
Liver transplant for hepatocellular carcinoma in the United States: Evolving trends over the last three decades.
Marc Puigvehí, Dana Hashim, Philipp K. Haber, Amreen Dinani, Thomas D. Schiano
American Journal of Transplantation. 2020-01-01

Press Mentions

NASHNET Celebrates International NASH Day with an Educational Podcast SeriesJune 12th, 2020
Rox Heart Radio: From the Front with Amreen DinaniMay 20th, 2020
JAMA Paper: In People with Opioid Use Disorder, Telemedicine Treatment for HCV Was More Than Twice as Successful as off-Site ReferralApril 9th, 2024